What is NTHI's preferred stock, par or stated value per share?

NTHI (NTHI) reported preferred stock, par or stated value per share of $0 in Q1 2026.

How has NTHI's preferred stock, par or stated value per share changed year-over-year?

NTHI's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.

NTHI NTHI Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Par or Stated Value Per Share at other companies

Crinetics PharmaceuticalsCRNX

——

Other financials

Income statement

See full

Revenue$40.0K-7.0%

Operating income-$7.1M+77.9%

Net income-$8.8M+72.7%

EPS (diluted)-$0.38+78.7%

Balance sheet

See full

Cash & equivalents$138.6K-97.5%

Total debt$666.1K—

Total equity-$13.2M-37.5%

Total assets$3.3M-60.6%

Cash flow

See full

Operating cash flow-$7.0M-23.7%

CapEx$125.0K—

Free cash flow-$5.2M—

Valuation

See full

Market cap$114.62M+51.0%

Enterprise value$115.15M+51.1%

P/S1,432.9×—

Profitability

See full

Operating margin-46,870.7%—

Net margin-51,613.3%—

FCF margin-26,083.2%—

Returns & leverage

See full

Return on equity338.1%—

Debt / equity-0.1×—

Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's preferred stock, par or stated value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NTHI's preferred stock, par or stated value per share?: NTHI (NTHI) reported preferred stock, par or stated value per share of $0 in Q1 2026.
How has NTHI's preferred stock, par or stated value per share changed year-over-year?: NTHI's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.